Glen Eagle Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$393K Sell
5,694
-1,625
-22% -$112K 0.06% 177
2025
Q1
$508K Sell
7,319
-4,149
-36% -$288K 0.08% 144
2024
Q4
$986K Sell
11,468
-260
-2% -$22.4K 0.16% 96
2024
Q3
$1.4M Buy
11,728
+1,103
+10% +$131K 0.24% 77
2024
Q2
$1.52M Buy
10,625
+1,591
+18% +$227K 0.28% 66
2024
Q1
$1.16M Buy
9,034
+1,281
+17% +$164K 0.22% 87
2023
Q4
$802K Sell
7,753
-3,726
-32% -$385K 0.17% 106
2023
Q3
$1.04M Buy
11,479
+9,105
+384% +$828K 0.24% 85
2023
Q2
$192K Buy
2,374
+2,332
+5,552% +$189K 0.04% 231
2023
Q1
$3.34K Sell
42
-4
-9% -$318 ﹤0.01% 781
2022
Q4
$3.11K Buy
+46
New +$3.11K ﹤0.01% 807
2022
Q2
Sell
-26
Closed -$1.44K 1020
2022
Q1
$1.44K Sell
26
-200
-88% -$11.1K ﹤0.01% 847
2021
Q4
$12.7K Sell
226
-774
-77% -$43.3K ﹤0.01% 582
2021
Q3
$48K Hold
1,000
0.01% 381
2021
Q2
$41.9K Hold
1,000
0.01% 409
2021
Q1
$33.7K Hold
1,000
0.01% 412
2020
Q4
$34.9K Hold
1,000
0.01% 387
2020
Q3
$34.7K Sell
1,000
-14
-1% -$486 0.02% 359
2020
Q2
$33.2K Buy
1,014
+14
+1% +$458 0.02% 347
2020
Q1
$30.1K Buy
1,000
+50
+5% +$1.51K 0.02% 333
2019
Q4
$27.5K Buy
950
+150
+19% +$4.34K 0.01% 415
2019
Q3
$20.7K Hold
800
0.01% 404
2019
Q2
$20.4K Hold
800
0.01% 396
2019
Q1
$20.9K Hold
800
0.02% 379
2018
Q4
$18.4K Hold
800
0.02% 375
2018
Q3
$18.9K Hold
800
0.01% 386
2018
Q2
$18.4K Hold
800
0.01% 373
2018
Q1
$19.7K Sell
800
-600
-43% -$14.8K 0.02% 344
2017
Q4
$37.6K Hold
1,400
0.03% 274
2017
Q3
$33.7K Sell
1,400
-950
-40% -$22.9K 0.03% 279
2017
Q2
$50.4K Hold
2,350
0.04% 218
2017
Q1
$40.3K Buy
2,350
+600
+34% +$10.3K 0.03% 220
2016
Q4
$31.4K Buy
+1,750
New +$31.4K 0.03% 240